Natera, Inc. (NTRA)
Services-Medical Laboratories
Latest Price
$328.93
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
12.79
P/B Ratio
25.71
Valuation metrics
adjust assumptions →Base FCF: $89M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$52.78
84% downside
Institutional Ownership
96.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | 12.87M | $3.50B | 8.96% | +11.0K | 2026-06-30 |
| BlackRock, Inc. | 10.91M | $2.96B | 7.60% | +237.3K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.02M | $2.45B | 6.28% | -3.16M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.23M | $1.69B | 4.34% | +219.7K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.78M | $1.57B | 4.03% | +137.9K | 2026-06-30 |
| FMR LLC | 5.45M | $1.48B | 3.80% | +2.90M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.04M | $1.10B | 2.81% | -727.9K | 2026-06-30 |
| STATE STREET CORP | 3.66M | $992.0M | 2.55% | +238.1K | 2026-06-30 |
| Duquesne Family Office LLC | 3.19M | $864.0M | 2.22% | +122.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.75M | $744.0M | 1.91% | -25.9K | 2026-06-30 |